ReviewMolecules (Basel, Switzerland)2026
Molecular Targets in Modern Cosmetic Science.
Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The field of cosmetic science is rapidly evolving due to advances in skin biology research and increasing demand for evidence-based, personalized skincare solutions. A key aspect of this progress is the targeted modulation of biological macromolecules involved in skin aging, pigmentation, inflammation, and tissue regeneration. This review highlights major molecular targets in modern cosmetic research, focusing on telomerase, histone deacetylases (particularly sirtuins), matrix metalloproteinases, antioxidant enzymes, CD44 receptor, tyrosinase, microphthalmia-associated transcription factor, and melanocortin receptors, all of which regulate processes such as DNA repair, gene expression, extracellular matrix remodeling, and melanogenesis. Recent findings indicate that natural and synthetic compounds can effectively modulate these targets, supporting anti-aging and depigmenting strategies. Telomerase activators and sirtuin modulators show potential in maintaining cellular homeostasis and delaying skin aging. In pigmentation research, the transition from mushroom to human tyrosinase assays has enabled development of more selective inhibitors, including thiamidol. The review also addresses molecular targets relevant to inflammatory skin disorders, scars, and skin atrophy. Advances in molecular and biotechnological methods are expected to improve mechanistic understanding and support the rational design of safer, more effective next-generation cosmetic ingredients and formulations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.